About Radiesse
Actual patient. Individual results may vary.
Learn about Radiesse®

The first and only CaHA injectable treatment in the U.S.

Actual patient. Individual results may vary.

Learn about Radiesse®

The first and only CaHA injectable treatment in the U.S.

What is CaHA?

Calcium hydroxylapatite, or CaHA, is what makes Radiesse unique as an injectable aesthetic treatment. It’s the first and only CaHA portfolio available that provides both immediate, natural-looking results and long-term improvement—a year or more in many patients.1-8

Radiesse Packaging

Immediate contouring plus stimulation of collagen and elastin* production you need1-8

What can Radiesse improve for you?

Radiesse is a one-of-a-kind injectable treatment—the only CaHA that’s FDA approved for use in the lower face and hands.1,2,10

Radiesse model, Jean, in royal blue
Actual patient. Individual results may vary.

CaHA is the Key

Calcium hydroxylapatite, or CaHA, is what makes Radiesse unique as a dermal filler treatment. RADIESSE® is composed of CaHA suspended in an aqueous gel carrier (ideal for injection).3

Upon injection, the Radiesse CaHA gel matrix provides immediate improvement.3-6

CaHA particles form a “scaffold” that stimulates fibroblasts to produce collagen for up to a year and elastin for up to nine months (after only one injection).5-10

For immediate, long-term rejuvenation:7,11,9

  • Immediately smooths wrinkles and folds
  • Long-term benefit from the stimulation of new collagen and elastin

Have more questions?

Check out these common questions for more info about Radiesse Injectables and what you might expect from treatment

Ready for a consultation?

Find a provider in your area and schedule a visit to see if a Radiesse treatment is right for you.

*Stimulation of collagen and elastin occurs when injected into the dermal layer.

References

  1. Radiesse (+) Instructions for use]. Franksville, WI: Merz North America, Inc; 2016.
  2. Radiesse Instructions for use]. Franksville, WI: Merz North America, Inc; 2016.
  3. Loghem JV, Yutskovskaya YA, Philip Werschler W. Calcium hydroxylapatite: over a decade of clinical experience. J Clin Aesthet Dermatol. 2015;8(1):38-49.
  4. Tzikas TL. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation. Dermatol Surg. 2008;34 Suppl 1:S9-15.
  5. Jansen DA, Graivier MH. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation. Plast Reconstr Surg. 2006;118(3 Suppl):22S-30S, discussion 31S-33S.
  6. Bass LS, Smith S, Busso M, McClaren M. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results. Aesthet Surg J. 2010;30(2):235-238.
  7. Yutskovskaya Y, Kogan E, Leshunov E. A ran- domized, split-face, histomorphologic study comparing a volumetric calcium hydroxylapatite and a hyaluronic acid-based dermal filler. J Drugs Dermatol. 2014;13(9):1047-1052.
  8. González N, Goldberg DJ. Evaluating the effects of injected calcium hydroxylapatite on changes in human skin elastin and proteoglycan formation. Dermatol Surg. 2019;45(4):547-551.
  9. Radiesse for Hands [Instructions for Use]. Franksville, WI. Merz North America, Inc; 2019.
  10. Goldman MP, Moradi A, Gold MH, et al. Calcium hydroxylapatite dermal filler for treatment of dorsal hand volume loss: results from a 12-month, multicenter, randomized, blinded trial. Dermatol Surg. 2018;44(1):75-83.

RADIESSE® is available only through licensed physicians.

Enter your zip code to find a licensed RADIESSE® provider.